Evidence map›Paper›PMID 25614712›Full record

ReviewMediators of inflammation2014

Neonatal sepsis and inflammatory mediators.

Juliana Reis Machado, Danilo Figueiredo Soave, Marcos Vinícius da Silva, Liliana Borges de Menezes, Renata Margarida Etchebehere, Maria Luiza Gonçalves dos Reis Monteiro, Marlene Antônia dos Reis, Rosana Rosa Miranda Corrêa, Mara Rúbia Nunes Celes

Open access · goldAbstract readReview
In one paragraph

Review in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Plasma transfusion in neonatal sepsis.World journal of pediatrics : WJP · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. AntenatalInternational journal of molecular sciences · 2024
    Article
  12. A practical predictive model to predict 30-day mortality in neonatal sepsis.Revista da Associacao Medica Brasileira (1992) · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. A New Target in Inflammatory Diseases: Lycopene.The Eurasian journal of medicine · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Juliana Reis MachadoDepartment of Pathology, Institute of Tropical Pathology and Public Health, Federal University of Goias, 74605-050 Goiania, GO, Brazil ; Department of General Pathology, Institute of Biological and Natural Sciences, Federal University of Triangulo Mineiro, 74605-050 Uberaba, MG, Brazil.
Danilo Figueiredo SoaveDepartment of Pathology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, 14049-900 Ribeirao Preto, SP, Brazil.
Marcos Vinícius da SilvaLaboratory of Immunology, Institute of Biological and Natural Sciences, Federal University of Triangulo Mineiro, 38025-180 Uberaba, MG, Brazil.
Liliana Borges de MenezesDepartment of Pathology, Institute of Tropical Pathology and Public Health, Federal University of Goias, 74605-050 Goiania, GO, Brazil.
Renata Margarida EtchebehereSurgical Pathology Service, Clinical Hospital, Federal University of Triangulo Mineiro, 38025-180 Uberaba, MG, Brazil.
Maria Luiza Gonçalves dos Reis MonteiroDepartment of General Pathology, Institute of Biological and Natural Sciences, Federal University of Triangulo Mineiro, 74605-050 Uberaba, MG, Brazil.
Marlene Antônia dos ReisDepartment of General Pathology, Institute of Biological and Natural Sciences, Federal University of Triangulo Mineiro, 74605-050 Uberaba, MG, Brazil.
Rosana Rosa Miranda CorrêaDepartment of General Pathology, Institute of Biological and Natural Sciences, Federal University of Triangulo Mineiro, 74605-050 Uberaba, MG, Brazil.
Mara Rúbia Nunes CelesDepartment of Pathology, Institute of Tropical Pathology and Public Health, Federal University of Goias, 74605-050 Goiania, GO, Brazil ; Department of Pathology, Faculty of Medicine of Ribeirao Preto, University of Sao Paulo, 14049-900 Ribeirao Preto, SP, Brazil.
Universidade Federal do Triângulo Mineiro · BRUniversidade de São Paulo · BRUniversidade Federal de Goiás · BR

Funding

Interhemispheric Research/Training in Infectious DiseaseD43TW007129 · FIC · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI TANOWITZ, HERBERT BERNARD · 2004 to 2013
$1.7M
FIC NIH HHS D43 TW007129FIC NIH HHS D43-TW007129
6 · The paper itself

Abstract

Neonatal sepsis is a major cause of morbidity and mortality and its signs and symptoms are nonspecific, which makes the diagnosis difficult. The routinely used laboratory tests are not effective methods of analysis, as they are extremely nonspecific and often cause inappropriate use of antibiotics. Sepsis is the result of an infection associated with a systemic inflammatory response with production and release of a wide range of inflammatory mediators. Cytokines are potent inflammatory mediators and their serum levels are increased during infections, so changes from other inflammatory effector molecules may occur. Although proinflammatory and anti-inflammatory cytokines have been identified as probable markers of neonatal infection, in order to characterize the inflammatory response during sepsis, it is necessary to analyze a panel of cytokines and not only the measurement of individual cytokines. Measurements of inflammatory mediators bring new options for diagnosing and following up neonatal sepsis, thus enabling early treatment and, as a result, increased neonatal survival. By taking into account the magnitude of neonatal sepsis, the aim of this review is to address the role of cytokines in the pathogenesis of neonatal sepsis and its value as a diagnostic criterion.

Indexed as

BiomarkersCytokinesHumansInfant, NewbornInflammationInterleukin-10Interleukin-1betaInterleukin-6Interleukin-8SepsisTransforming Growth Factor betaTreatment OutcomeTumor Necrosis Factor-alphaBiomarkersCXCL8 protein, humanCytokinesIL10 protein, humanIL6 protein, humanInterleukin-10Interleukin-1betaInterleukin-6Interleukin-8Transforming Growth Factor betaTumor Necrosis Factor-alpha

Identifiers

PMID25614712
PMCPMC4295603
OpenAlexW2134575990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.